Mandate

Vinge advises AstraZeneca on the sale of a pharmaceutical portfolio

June 04, 2007

Vinge is advising AstraZeneca on the sale of a large number of pharmaceuticals to Recip AB. The sale includes a portfolio of infection drugs for sale in Sweden, Norway, Denmark and Iceland. The annual sales of the 17 drugs included in the portfolio are SEK 240 million.

AstraZeneca is represented by partner Malin Leffler, assisted by Anna Berntsson and Claes Henriksson.

Related

Vinge advises Platzer on the acquisition of a logistics property in Sörred Logistics Park

Vinge has advised Platzer on the acquisition of the property Sörred 8:15 in Sörred Logistics Park in Hisingen in Gothenburg. The acquisition is performed in accordance with the purchase option held by Platzer in the joint venture with Catena, which grants priority to acquire completed projects at market value. The purchase price is based on an underlying property value of SEK 570 million, less deferred tax. Closing is expected to take place on 1 July 2026.
June 02, 2026

Vinge advises the owners in conjunction with change of ownership at Norteam

Evolver Equity has become the new majority owner of Norteam AB, a fast-growing Swedish specialist in Microsoft Cloud. Co-founder Martin Norström is reinvesting in the new group and taking on the role of Group CEO. The investment marks the start of a Nordic growth journey with the ambition of building a leading provider of Microsoft-based IT services for small and medium-sized enterprises – and of reaching SEK 1 billion in revenue within 3–5 years.
June 02, 2026

Vinge advises TSG on the acquisition of Processkontroll GT

TSG, a European leader in technical services for sustainable mobility solutions and critical energy infrastructure, has acquired Processkontroll GT, a specialist in compressed and liquid gas infrastructure.
June 01, 2026